Read More Pharma Industry News AbbVie and Calico secure FDA fast track designation for kidney disease therapy ABBV-CLS-628 AbbVie and Calico’s kidney drug ABBV-CLS-628 wins FDA Fast Track status for ADPKD, reshaping biotech strategy and investor sentiment. byPallavi MadhirajuOctober 2, 2025